RxSight, Inc.
RXST

NASDAQ > Medical - Devices
0  |   P/E: -
$0.65(1.92%)
Change
Rating:
Price: $33.66 USD
Market Cap: $1.38B

...Loading RXST Peers...





RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

    374 Employees

    CEO : Dr. Ronald M. Kurtz M.D.

    Address : 100 Columbia, Aliso Viejo,CA, US, - 92656,

Key ExcutivesDesignation
Ms. Shelley B. ThunenCo-President & Chief Financial Officer
Dr. Ronald M. Kurtz M.D.President, Chief Executive Officer & Director
Mr. Eric J. WeinbergCo-President & Chief Commercial Officer
Mr. Oliver MoravcevicVice President of Investor Relations
Ms. Caroline VaughnVice President of Human Resources
Dr. Ilya Goldshleger Ph.D.Co-President & Chief Operating Officer
Mr. Roy FreemanSenior Vice President of Marketing & Professional Relations
Mr. Matt Haller Ph.D.Chief Technology Officer
Ms. Rebecca WillistonVice President of Accounting & Finance
Mr. Steve EverlySenior Vice President of Sales of North America